List of works - Sekar Natesampillai

An advanced BLT-humanized mouse model for extended HIV-1 cure studies.

scientific article

Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment

scientific article published on 20 December 2017

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation

scientific article

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.

scientific article

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells

scientific article

Correction: Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment

scientific article published on 13 July 2018

HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome.

scientific article published on 11 April 2018

HIV elite control is associated with reduced TRAILshort expression

scientific article published on 01 September 2019

Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells

scientific article

Isolation of a TRAIL antagonist from the serum of HIV-infected patients.

scientific article

Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

scientific article published on 22 March 2017

Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.

scientific article

Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size

scientific article published on 3 February 2016

TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes

scientific article

TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection

scientific article published on 12 June 2019

The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak

scientific article

List of works by Sekar Natesampillai

An advanced BLT-humanized mouse model for extended HIV-1 cure studies.

Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation

Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation.

Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells

Correction: Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment

HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome.

HIV elite control is associated with reduced TRAILshort expression

Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells

Isolation of a TRAIL antagonist from the serum of HIV-infected patients.

Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.

Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size

TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes

TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection

The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak